Prognostic impact of combined immunoprofiles in oropharyngeal
squamous cell carcinoma patients with respect to AJCC 8th
edition

J 2018

Prognostic impact of combined immunoprofiles in oropharyngeal squamous cell carcinoma patients with respect to AJCC 8th edition

GURÍN, Dominik, Marek SLÁVIK, Markéta HERMANOVÁ, Tetiana SHATOKHINA, Jiří ŠÁNA et. al.

Základní údaje

Originální název

Prognostic impact of combined immunoprofiles in oropharyngeal squamous cell carcinoma patients with respect to AJCC 8th edition

Autoři

GURÍN, Dominik (203 Česká republika, domácí), Marek SLÁVIK (703 Slovensko, domácí), Markéta HERMANOVÁ (203 Česká republika, domácí), Tetiana SHATOKHINA (804 Ukrajina, domácí), Jiří ŠÁNA (203 Česká republika, domácí), Tomáš KAZDA (203 Česká republika, domácí), Iveta SELINGEROVÁ (203 Česká republika, domácí), Parwez AHMAD (356 Indie, domácí), Pavel SMILEK (203 Česká republika, domácí), Zuzana HORÁKOVÁ (203 Česká republika, domácí), Michal HENDRYCH (203 Česká republika, domácí), Pavel ŠLAMPA (203 Česká republika, domácí) a Ondřej SLABÝ (203 Česká republika, domácí)

Vydání

JOURNAL OF ORAL PATHOLOGY & MEDICINE, HOBOKEN, WILEY, 2018, 0904-2512

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30109 Pathology

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 2.030

Kód RIV

RIV/00216224:14110/18:00106945

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1111/jop.12772

UT WoS

000446836900009

Klíčová slova anglicky

CD44; combined immunoprofiles; EGFR; OPSCC; p16

Štítky

14110112, 14110126, 14110515, 14110812, podil, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 7. 3. 2019 16:36, Mgr. Pavla Foltynová, Ph.D.

Anotace

V originále

ObjectivesTo examine combined immunoprofiles of epidermal growth factor receptor (EGFR), CD44, and p16 in oropharyngeal squamous cell carcinoma (OPSCC) and to correlate them with radiotherapy treatment outcomes and clinicopathological parameters. Prognostic impact of the American Joint Committee on Cancer (AJCC) 8th edition staging system in comparison with 7th edition was analyzed. MethodsThe study included 77 OPSCC patients treated by definitive intensity-modulated radiotherapy (IMRT). Clinical staging was assessed according to the AJCC, both 7th and 8th edition. Immunohistochemical (IHC) analysis of CD44 and EGFR was performed on primary biopsy tumor tissues. To evaluate the HPV status, IHC detection of p16 was employed. ResultsThe AJCC 8th edition staging system revealed correlations between overall survival (OS), progression-free survival (PFS), locoregional control (LRC), and clinical stage. EGFR and CD44 positivity (+) and p16 negativity (-) were associated with clinical stage IV of the disease. CD44+ and EGFR+ OPSCC displayed worse OS and LRC, and these cases also showed the worst 3-year OS and LRC. Combined analysis of protein expressions identified an association between p16- and EGFR+, p16- and CD44+, EGFR+, and CD44+. Combined immunoprofiles CD44+/p16-, EGFR+/p16-, and EGFR+/CD44+ were associated with worst OS and LRC. ConclusionsCombined immunoprofiles of p16, EGFR, and CD44 might provide valuable prognostic and predictive information for the individual OPSCC patients, especially in terms of response to IMRT and prediction of treatment outcomes. Application of the AJCC 8th edition staging for HPV+ OPSCC proved to improve hazard discrimination and prognostication of OPSCC.

Návaznosti

NV15-31627A, projekt VaV

Název: Možnosti molekulárně řízené radikální radioterapie nebo radiochemoterapie dle profilu mikroRNA u pacientů se spinocelulárními karcinomy hlavy a krku.

Citovat

GURÍN, Dominik, Marek SLÁVIK, Markéta HERMANOVÁ, Tetiana SHATOKHINA, Jiří ŠÁNA, Tomáš KAZDA, Iveta SELINGEROVÁ, Parwez AHMAD, Pavel SMILEK, Zuzana HORÁKOVÁ, Michal HENDRYCH, Pavel ŠLAMPA a Ondřej SLABÝ. Prognostic impact of combined immunoprofiles in oropharyngeal squamous cell carcinoma patients with respect to AJCC 8th edition. JOURNAL OF ORAL PATHOLOGY & MEDICINE. HOBOKEN: WILEY, 2018, roč. 47, č. 9, s. 864-872. ISSN 0904-2512. Dostupné z: https://dx.doi.org/10.1111/jop.12772.

@article{1466236,
   author = {Gurín, Dominik and Slávik, Marek and Hermanová, Markéta and Shatokhina, Tetiana and Šána, Jiří and Kazda, Tomáš and Selingerová, Iveta and Ahmad, Parwez and Smilek, Pavel and Horáková, Zuzana and Hendrych, Michal and Šlampa, Pavel and Slabý, Ondřej},
   article_location = {HOBOKEN},
   article_number = {9},
   doi = {http://dx.doi.org/10.1111/jop.12772},
   keywords = {CD44; combined immunoprofiles; EGFR; OPSCC; p16},
   language = {eng},
   issn = {0904-2512},
   journal = {JOURNAL OF ORAL PATHOLOGY & MEDICINE},
   title = {Prognostic impact of combined immunoprofiles in oropharyngeal squamous cell carcinoma patients with respect to AJCC 8th edition},
   volume = {47},
   year = {2018}
}

TY  - JOUR
ID  - 1466236
AU  - Gurín, Dominik - Slávik, Marek - Hermanová, Markéta - Shatokhina, Tetiana - Šána, Jiří - Kazda, Tomáš - Selingerová, Iveta - Ahmad, Parwez - Smilek, Pavel - Horáková, Zuzana - Hendrych, Michal - Šlampa, Pavel - Slabý, Ondřej
PY  - 2018
TI  - Prognostic impact of combined immunoprofiles in oropharyngeal squamous cell carcinoma patients with respect to AJCC 8th edition
JF  - JOURNAL OF ORAL PATHOLOGY & MEDICINE
VL  - 47
IS  - 9
SP  - 864-872
EP  - 864-872
PB  - WILEY
SN  - 09042512
KW  - CD44
KW  - combined immunoprofiles
KW  - EGFR
KW  - OPSCC
KW  - p16
N2  - ObjectivesTo examine combined immunoprofiles of epidermal growth factor receptor (EGFR), CD44, and p16 in oropharyngeal squamous cell carcinoma (OPSCC) and to correlate them with radiotherapy treatment outcomes and clinicopathological parameters. Prognostic impact of the American Joint Committee on Cancer (AJCC) 8th edition staging system in comparison with 7th edition was analyzed. MethodsThe study included 77 OPSCC patients treated by definitive intensity-modulated radiotherapy (IMRT). Clinical staging was assessed according to the AJCC, both 7th and 8th edition. Immunohistochemical (IHC) analysis of CD44 and EGFR was performed on primary biopsy tumor tissues. To evaluate the HPV status, IHC detection of p16 was employed. ResultsThe AJCC 8th edition staging system revealed correlations between overall survival (OS), progression-free survival (PFS), locoregional control (LRC), and clinical stage. EGFR and CD44 positivity (+) and p16 negativity (-) were associated with clinical stage IV of the disease. CD44+ and EGFR+ OPSCC displayed worse OS and LRC, and these cases also showed the worst 3-year OS and LRC. Combined analysis of protein expressions identified an association between p16- and EGFR+, p16- and CD44+, EGFR+, and CD44+. Combined immunoprofiles CD44+/p16-, EGFR+/p16-, and EGFR+/CD44+ were associated with worst OS and LRC. ConclusionsCombined immunoprofiles of p16, EGFR, and CD44 might provide valuable prognostic and predictive information for the individual OPSCC patients, especially in terms of response to IMRT and prediction of treatment outcomes. Application of the AJCC 8th edition staging for HPV+ OPSCC proved to improve hazard discrimination and prognostication of OPSCC.
ER  -

GURÍN, Dominik, Marek SLÁVIK, Markéta HERMANOVÁ, Tetiana SHATOKHINA, Jiří ŠÁNA, Tomáš KAZDA, Iveta SELINGEROVÁ, Parwez AHMAD, Pavel SMILEK, Zuzana HORÁKOVÁ, Michal HENDRYCH, Pavel ŠLAMPA a Ondřej SLABÝ. Prognostic impact of combined immunoprofiles in oropharyngeal squamous cell carcinoma patients with respect to AJCC 8th edition. \textit{JOURNAL OF ORAL PATHOLOGY \&{}amp; MEDICINE}. HOBOKEN: WILEY, 2018, roč.~47, č.~9, s.~864-872. ISSN~0904-2512. Dostupné z: https://dx.doi.org/10.1111/jop.12772.

Podrobný výpis o publikaci